Skip to main content
    M

    Myriad Genetics Inc (MYGN)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $5.54
    -0.03 (-0.54%)

    Market Cap: $542.92M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Myriad Genetics Inc (MYGN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Myriad Genetics (MYGN) has a latest price of $5.54 on Nov 17, 2026, 31.5% below its 52-week high of $8.09. Its price fell 17.4% over the past 12 months. The month-end price fell 67.8% over the 10 years through Oct 2026, a compound annual decline of 10.7%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $49.79 in Aug 2018 and its lowest $2.86 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MYGN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MYGN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 73.7%, and over 6 months it rose 56.1%. The month-end price fell 59.2% over the 3 years through Oct 2026, a compound annual decline of 25.9%.

    PeriodChange
    1 month+31.6%
    3 months+73.7%
    6 months+56.1%
    12 months-17.4%
    12 months, with dividends-17.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-59.2%-25.9%
    5 years-79.4%-27.1%
    10 years-67.8%-10.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 106.1%, and its weakest was 2025, when it fell 55.1%.

    YearCloseChange
    2026 through Oct 2026$6.35+3.3%
    2025$6.15-55.1%
    2024$13.71-28.4%
    2023$19.14+31.9%
    2022$14.51-47.4%
    2021$27.60+39.6%
    2020$19.77-27.4%
    2019$27.23-6.3%
    2018$29.07-15.4%
    2017$34.35+106.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 14.4% above its 50-day average of $4.84 and 20.2% above its 200-day average of $4.61.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$5.54
    52-week high$8.09-31.5%
    52-week low$2.74+102.2%
    50-day average$4.84+14.4%
    200-day average$4.61+20.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 90.0%.

    MeasureValue
    1-year beta0.63
    Largest fall, 1 year-63.8%
    Largest fall, 3 years-90.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MYGN

    What is MYGN's 1-year price change?

    Myriad Genetics's price fell 17.4% over the past 12 months. With dividends included, the 12-month total return was -17.4%.

    What is MYGN's 5-year price change?

    Myriad Genetics's month-end price fell 79.4% over the 5 years through Oct 2026, a compound annual decline of 27.1%. These figures leave out dividends.

    What is MYGN's 52-week high and low?

    Myriad Genetics's 52-week high is $8.09 and its 52-week low is $2.74. Its latest price of $5.54 on Nov 17, 2026 is 31.5% below the high.

    What is MYGN's beta?

    Myriad Genetics's 1-year beta against the S&P 500 is 0.63, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 63.8%.

    Is the MYGN chart free?

    Yes. Advanced Charting for MYGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.